DE2318002A1 - Eckige klammer auf alpha-(3-trifluormethylphenoxy)-4-chlorbenzyl eckige klammer zu -heterocyclen - Google Patents

Eckige klammer auf alpha-(3-trifluormethylphenoxy)-4-chlorbenzyl eckige klammer zu -heterocyclen

Info

Publication number
DE2318002A1
DE2318002A1 DE2318002A DE2318002A DE2318002A1 DE 2318002 A1 DE2318002 A1 DE 2318002A1 DE 2318002 A DE2318002 A DE 2318002A DE 2318002 A DE2318002 A DE 2318002A DE 2318002 A1 DE2318002 A1 DE 2318002A1
Authority
DE
Germany
Prior art keywords
radical
compound
trifluoromethylphenoxy
azide
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2318002A
Other languages
German (de)
English (en)
Inventor
William Alfred Bolhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2318002A1 publication Critical patent/DE2318002A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2318002A 1972-04-11 1973-04-10 Eckige klammer auf alpha-(3-trifluormethylphenoxy)-4-chlorbenzyl eckige klammer zu -heterocyclen Pending DE2318002A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00243480A US3816446A (en) 1972-04-11 1972-04-11 (alpha-(3-trifluoromethylphenoxy)-4-chlorobenzyl)heterocycles

Publications (1)

Publication Number Publication Date
DE2318002A1 true DE2318002A1 (de) 1973-10-31

Family

ID=22918919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2318002A Pending DE2318002A1 (de) 1972-04-11 1973-04-10 Eckige klammer auf alpha-(3-trifluormethylphenoxy)-4-chlorbenzyl eckige klammer zu -heterocyclen

Country Status (9)

Country Link
US (1) US3816446A (US20050192411A1-20050901-C00001.png)
JP (1) JPS5030620B2 (US20050192411A1-20050901-C00001.png)
CH (1) CH589636A5 (US20050192411A1-20050901-C00001.png)
DE (1) DE2318002A1 (US20050192411A1-20050901-C00001.png)
DK (1) DK136976B (US20050192411A1-20050901-C00001.png)
FR (1) FR2182952B1 (US20050192411A1-20050901-C00001.png)
GB (1) GB1388790A (US20050192411A1-20050901-C00001.png)
NL (1) NL7304333A (US20050192411A1-20050901-C00001.png)
SE (1) SE380524B (US20050192411A1-20050901-C00001.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355820A1 (en) * 1988-08-23 1990-02-28 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazol-1-yl compounds

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953465A (en) * 1972-04-11 1976-04-27 Merck & Co., Inc. 2-[α-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and methods for preparing the same
US3953490A (en) * 1972-07-13 1976-04-27 Merck & Co., Inc. Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
JPS50116306U (US20050192411A1-20050901-C00001.png) * 1974-03-05 1975-09-22
JPS50137193U (US20050192411A1-20050901-C00001.png) * 1974-04-25 1975-11-12
JPS5111502A (ja) * 1974-07-19 1976-01-29 Matsushita Electric Ind Co Ltd Senkyokusochi
JPS544877Y2 (US20050192411A1-20050901-C00001.png) * 1976-12-03 1979-03-01
EP0035475B1 (de) * 1980-03-05 1983-11-30 Ciba-Geigy Ag Herbizid wirkende 2-Nitro-5-phenoxyphenyl-oxazole, -oxazine, -imidazole, -pyrimidine und -thiazole, ihre Herstellung und Verwendung
FR2766821A1 (fr) * 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
CA2437118A1 (en) * 2001-02-09 2002-08-22 Merck & Co., Inc. 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
KR20070011312A (ko) * 2004-02-18 2007-01-24 메타볼렉스, 인코포레이티드 항당뇨병제로서 알파-(트리플루오로메틸-치환된 아릴옥시,아릴아미노, 아릴티오 또는아릴메틸)-트리플루오로메틸-치환된 페닐아세트산 및 이의유도체
CA2567437A1 (en) 2004-05-25 2005-12-08 Metabolex, Inc. Substituted triazoles as modulators of ppar and methods of their preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355820A1 (en) * 1988-08-23 1990-02-28 Bristol-Myers Squibb Company Antihypercholesterolemic tetrazol-1-yl compounds

Also Published As

Publication number Publication date
DK136976C (US20050192411A1-20050901-C00001.png) 1978-06-05
CH589636A5 (US20050192411A1-20050901-C00001.png) 1977-07-15
SE380524B (sv) 1975-11-10
FR2182952B1 (US20050192411A1-20050901-C00001.png) 1975-10-31
JPS497275A (US20050192411A1-20050901-C00001.png) 1974-01-22
US3816446A (en) 1974-06-11
NL7304333A (US20050192411A1-20050901-C00001.png) 1973-10-15
JPS5030620B2 (US20050192411A1-20050901-C00001.png) 1975-10-02
DK136976B (da) 1977-12-27
GB1388790A (en) 1975-03-26
FR2182952A1 (US20050192411A1-20050901-C00001.png) 1973-12-14

Similar Documents

Publication Publication Date Title
DE1445154B2 (de) 1,4-dihydro-1,8-naphthyridinderivate und ein verfahren zu ihrer herstellung
DE2445584A1 (de) Aminosaeureester
EP0023594B1 (de) Trans-Chinazolinderivate, Verfahren zu ihrer Herstellung, Zwischenprodukte und Arzneimittel enthaltend solche Chinazolinderivate
DE2318002A1 (de) Eckige klammer auf alpha-(3-trifluormethylphenoxy)-4-chlorbenzyl eckige klammer zu -heterocyclen
DE2657978C3 (de) Linksdrehende Enantiomere und Racemate von Trifluormethylthio(und -sulfonyl)cyproheptadinderivaten, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
DE2351411C2 (de) (1-Oxo-2,3-hydrocarbylen-6,7-dichlor-5- indanyloxy)-essigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
EP0027268A2 (de) Chinazolin-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung, Arzneimittel enthaltend solche Chinazolin-Derivate und deren pharmazeutische Verwendung
DE2554882A1 (de) Fluorierte verbindungen
DE2519059A1 (de) Neue aminoderivate von 6-phenylpyrazolo(3.4-b)pyridinen
DE2624352B2 (de) Dibenzo ecklige Klammer auf b,f] thiepine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende entzündungshemmende Zubereitungen
CH616935A5 (en) Process for the preparation of chromone derivatives
EP0088323B1 (de) Imidazothiadiazolalkencarbonsäureamide, neue Zwischenprodukte zu ihrer Herstellung, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE2054142A1 (de) Pyridinsulfonsauren
DE2411552A1 (de) Derivate von benzodiazepinonen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2934375A1 (de) Hydroxyessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
EP0012801A1 (de) 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel
DE3538063A1 (de) 6-phenethylaminoalkyl-furo-(3,4-c)-pyridinderivate, verfahren zu deren herstellung und diese enthaltende therapeutische zusammensetzungen
DE2520131A1 (de) Stickstoffhaltige polycyclische verbindungen und verfahren zu deren herstellung
DD290887A5 (de) Neue rifamycinderivate
EP0054672A1 (de) Lactamverbindungen, diese enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
WO1979000116A1 (en) New glycol compounds for lowering the lipid content
DE2536387A1 (de) Pyrido(3,2-e)-as-triazinderivate, solche enthaltende arzneimittel sowie verfahren zur herstellung derselben
AT367740B (de) Verfahren zur herstellung von neuen omega-(2(n-niederalkyl-benzamido)-phenyl)-alkansaeuren und ihren salzen
CH640210A5 (en) ML-236B carboxylic acid derivatives and compositions for the treatment of hyperlipaemia